Validation of molecular and genomic biomarkers of retinal drug efficacy: Use of ocular fluid sampling to evaluate VEGF

Neurochemical Research

Volumn 36, Issue 4, 2011, Pages 655-667

  Sharma, Rajesh K ^a   Rowe Rendleman, Cheryl L ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b Omar Consulting Group LLC   (United States)

Author keywords

Aqueous humor; Biomarkers; Ocular; Retinal disease; Validation; Vascular endothelial growth factor

Indexed keywords

ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BASIC FIBROBLAST GROWTH FACTOR; BETA2 GLYCOPROTEIN 1; BEVACIZUMAB; C REACTIVE PROTEIN; CD40 ANTIGEN; CREATINE KINASE MB; ENDOTHELIN 1; EOTAXIN; ERYTHROPOIETIN; FATTY ACID BINDING PROTEIN; FIBRINOGEN; GLUTATHIONE TRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; LEPTIN; LYMPHOTOXIN; MYOGLOBIN; PEGAPTANIB; RANTES; SERUM AMYLOID P; STEM CELL FACTOR; STROMELYSIN; TRIAMCINOLONE; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165;

AMINO ACID SEQUENCE; AQUEOUS HUMOR SAMPLING; ARTICLE; BIOCHIP; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CHEMOLUMINESCENCE; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC MARKER; HUMAN; LOW DRUG DOSE; MYOPIA; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA MACULA HOLE; SAMPLING; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; UVEA MELANOMA; VALIDATION STUDY; VISUAL SYSTEM EXAMINATION; VITREOUS BODY;

AQUEOUS HUMOR; BIOLOGICAL MARKERS; DRUG THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 79954596619     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0328-7     Document Type: Article

References (55)

1. US Department of Health and Human Services (2008) Guidance for industry: E15 definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/ucm129296.pdf Published April 2008. Accessed 28 July 2010
2. National Collaborating Centre for Cancer (2009) Advanced breast cancer: diagnosis and treatment. London (UK): National Institute for Health and Clinical Excellence (NICE). http://www.guideline.gov/content.aspx?id=14311&search= trastuzumab. Published February 2009. Accessed 7 Nov 2010
3. HT Siljander S Simell A Hekkala 2009 Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population Diabetes 58 2835 2842 19755526 10.2337/db08-1305 1:CAS:528:DC%2BD1MXhsFKlurfL
4. N Murukesh C Dive GC Jayson 2010 Biomarkers of angiogenesis and their role in the development of VEGF inhibitors Br J Cancer 102 8 18 20010945 10.1038/sj.bjc.6605483 1:CAS:528:DC%2BC3cXhtFOltA%3D%3D
5. F Goodsaid F Frueh 2007 Biomarker qualification pilot process at the US food and drug administration AAPS J 9 E105 E108 17408233 10.1208/aapsj0901010 1:CAS:528:DC%2BD2sXksFGktrg%3D
6. AJ Atkinson WA Colburn VG DeGruttola, et al. 2001 Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89 95 10.1067/mcp.2001.113989 (Pubitemid 32225406)
7. Shen J, Samul R, Silva RL (2006) Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1: knockdown of vegfr1 mRNA inhibits ocular neovascularization. Gene Ther 13: 225-234 (Pubitemid 43148645)
8. N Shams Y Ianchulev 2006 Role of vascular endothelial growth factor in ocular angiogenesis Ophthalmol Clin North Am 19 335 344 16935208 (Pubitemid 44279356)
9. TA Ciulla PJ Rosenfeld 2009 Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration Curr Opin Ophthalmol 20 158 165 19417570 10.1097/ICU.0b013e32832d25b3
10. MJ Tolentino 2009 Current molecular understanding and future treatment strategies for pathologic ocular neovascularization Curr Mol Med 9 973 981 19925410 10.2174/156652409789712783 1:CAS:528:DC%2BD1MXhsFGqtLzN
11. JS Rudge J Holash D Hylton, et al. 2007 VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade PNAS 104 18363 18370 18000042 10.1073/pnas.0708865104 1:CAS:528:DC%2BD2sXhtl2ku73N (Pubitemid 350210713)
12. Ew Ng AP Adamis 2005 Targeting angiogenesis, the underlying disorder in noevascular age-related macular degeneration Can J Ophthalmol 40 352 368 15947805 (Pubitemid 40942262)
13. N Ferrara L Damic N Sham, et al. 2006 Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for noevascular age-related macular degeneration Retina 26 859 870 17031284 10.1097/01.iae.0000242842.14624.e7 (Pubitemid 44547437)
14. GA Vemulakonda SM Hariprasad WF Mieler, et al. 2008 Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans Arch Ophthalmol 126 1 18 22 18195213 10.1001/archophthalmol.2007.8 1:CAS:528:DC%2BD1cXhslSlurY%3D
15. A Van der Lelij A Rothova 1997 Diagnositic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 81 976 979 9505822 10.1136/bjo.81.11.976 (Pubitemid 27493985)
16. PA Campochiaro DF Choy DV Do, et al. 2009 Monitoring ocular drug therapy by analysis of aqueous samples Ophthalmol 116 11 2158 2164 10.1016/j.ophtha. 2009.04.038
17. RK Sharma AT Rogojina KV Chalam 2009 Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor Mol Vis 15 60 69 19145248 1:CAS:528:DC%2BD1MXhtlWgs74%3D
18. B Regenfuss F Bock A Parthasarathy C Cursiefen 2008 Corneal (lymph)angiogenesis-from bedside to bench and back: a tribute to Judah Folkman Lymphat Res Biol 6 191 201 19093792 10.1089/lrb.2008.6348
19. MJ Cross J Dixelius T Matsumoto L Claesson-Welsh 2003 VEGF-receptor signal transduction Tren Biochem Sci 28 488 494 10.1016/S0968-0004(03)00193-2 1:CAS:528:DC%2BD3sXnt1ylsLs%3D (Pubitemid 38340413)
20. M Shibuya 2009 Unique signal transduction of the VEGF family members VEGF-A and VEGF-E Biochem Soc Trans 37 1161 1166 19909239 10.1042/BST0371161 1:CAS:528:DC%2BD1MXhsVersr7J
21. Ranibizumab Full Prescribing Information, Genentech, South San Francisco 2007
22. Pegaptanib, Full Prescribing Information, OSI-Pfizer, NY, NY, 2004
23. FT Wu MO Stefanini F Mac Gabhann CD Kontos BH Annex, et al. 2010 VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model Am J Physiol Heart Circ Physiol 298 6 H2174 H2191 20382861 10.1152/ajpheart.00365.2009 1:CAS:528:DC%2BC3cXnslCgu7c%3D
24. J Miller AP Adamis D Shima PA D'Amore RS Moulton, et al. 1994 Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model Am J Pathol 145 574 584 7521577 1:CAS:528:DyaK2cXmvFygtrs%3D (Pubitemid 24285965)
25. PF Lopez BD Sippy HM Lambert AB Thach DR Hinton 1996 Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes Invest Ophthalmol Vis Sci 37 855 868 8603870 1:STN:280:DyaK287otFCnsQ%3D%3D
26. S Ishida T Usui K Yamashiro Y Kaji S Amano, et al. 2003 VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization J Exp Med 198 483 489 12900522 10.1084/jem.20022027 1:CAS:528:DC%2BD3sXmt1Ggsrg%3D (Pubitemid 36976059)
27. M Funk D Karl M Georgopoulos T Benesch S Sacu, et al. 2010 Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab Ophthalmol 116 2393 2399 10.1016/j.ophtha.2009.05.039
28. JA Wells R Murthy R Chibber A Nunn PA Molinatti, et al. 1996 Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation Br J Ophthalmol 80 4 363 366 8703891 10.1136/bjo.80.4.363 1:STN:280:DyaK283ps1ahsw%3D%3D (Pubitemid 26113591)
29. H Itakura S Kishi N Kotajima M Murakami 2004 Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy Ophthalmology 111 1880 1884 15465550 10.1016/j.ophtha.2004.03.035 (Pubitemid 39311840)
30. HL Brooks Jr S Caballero Jr CK Newell RL Steinmetz D Watson, et al. 2004 Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone Arch Ophthalmol 122 1801 1807 15596583 10.1001/archopht.122.12.1801 1:CAS:528:DC%2BD2MXjt1yrtA%3D%3D (Pubitemid 39602140)
31. H Funatsu H Yamashita K Sakata H Noma T Mimura, et al. 2005 Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema Ophthalmology 112 5 806 816 15878060 10.1016/j.ophtha.2004.11.045 (Pubitemid 40631499)
32. H Funatsu H Yamashita S Nakamura T Mimura S Eguchi, et al. 2006 Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema Ophthalmology 113 294 301 16406543 10.1016/j.ophtha.2005.10.030 (Pubitemid 43170779)
33. H Noma H Funatsu T Mimura S Harino S Hori 2009 Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion Ophthalmology 116 87 93 19118700 10.1016/j.ophtha.2008.09.034
34. D Watanabe K Suzuma I Suzuma H Ohashi T Ojima, et al. 2005 Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy Am J Ophthalmol 139 476 481 15767056 10.1016/j.ajo.2004.10.004 1:CAS:528:DC%2BD2MXjt1Klu7k%3D (Pubitemid 40379074)
35. E Ishizaki S Takai M Ueki T Maeno M Maruichi, et al. 2006 Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic Am J Ophthalmol 141 129 134 16386986 10.1016/j.ajo.2005.08.066 1:CAS:528:DC%2BD2MXhtlGlsrnP (Pubitemid 43016182)
36. M Sydorova MS Lee 2005 Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy Ophthalmic Res 37 188 190 15990461 10.1159/000086594 1:CAS:528:DC%2BD2MXpvVWjurY%3D (Pubitemid 41404758)
37. H Funatsu H Yamashita T Mimura S Nakamura, et al. 2005 Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients Graefes Arch Clin Exp Ophthalmol 243 3 8 15258777 10.1007/s00417-004-0950-7 1:CAS:528:DC%2BD2MXltVWmsA%3D%3D
38. H Noma H Funatsu T Mimura K Shimada 2010 Increase in aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study J Inflam 7 44 50 10.1186/1476-9255-7-44
39. JP Tong WM Chan DT Liu TY Lai KW Choy, et al. 2006 Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 456 462 16490490 10.1016/j.ajo.2005.10.012 1:CAS:528: DC%2BD28XhsFGgtr0%3D (Pubitemid 43265948)
40. GS Missotten IC Notting RO Schlingemann HJ Zijlmans C Lau, et al. 2006 Vascular endothelial growth factor a in eyes with uveal melanoma Arch Ophthalmol 124 1428 1434 17030710 10.1001/archopht.124.10.1428 1:CAS:528: DC%2BD28XhtFOms7rF (Pubitemid 44537143)
41. JB Jonas M Neumaier 2007 Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema Ophthalmic Res 39 139 142 17505145 10.1159/000102935 1:CAS:528:DC%2BD2sXmvFSmsLk%3D (Pubitemid 46975978)
42. MI Roh HS Kim JH Song JB Lim OW Kwon 2009 Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema Ophthalmol 116 80 86 10.1016/j.ophtha.2008.09.036
43. K Matsuyama N Ogata N Jo C Shima M Matsuoka, et al. 2009 Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab Jpn J Ophthalmol 53 243 248 19484443 10.1007/s10384-008-0645-4 1:CAS:528:DC%2BD1MXms1Ogu7Y%3D
44. TY Lai DT Liu KP Chan FO Luk CP Pang, et al. 2009 Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trial Retina 29 1218 1226 19934816 10.1097/IAE.0b013e3181b32c45
45. SP Park JK Ahn GH Mun 2010 Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion Retina 30 281 286 19881397 10.1097/IAE.0b013e3181b9f153
46. F Forooghian PJ Kertes KT Eng E Agrón EY Chew 2010 Alterations in the intraocular cytokine milieu after intravitreal bevacizumab Invest Ophthalmol Vis Sci 51 2388 2392 20007836 10.1167/iovs.09-4065
47. R Simo E Carrasco M Garcia-Ramirez, et al. 2006 Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy Curr Diabetes Rev 2 71 98 18220619 10.2174/157339906775473671 1:CAS:528:DC%2BD28XjtVGjtLw%3D (Pubitemid 44082952)
48. C Bulcao SR Ferreira FM Giuffrida, et al. 2006 The new adipose tissue and adipocytokines Curr Diabetes Rev 2 19 28 18220614 10.2174/157339906775473617 1:CAS:528:DC%2BD28XjtVGjt7k%3D (Pubitemid 44096614)
49. SK Kim RF Novak 2007 The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression Pharmacol Ther 113 88 120 17097148 10.1016/j.pharmthera.2006.07.004 1:CAS:528:DC%2BD2sXhsFCrtA%3D%3D (Pubitemid 44969928)
50. A Rabinovitch 1998 An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus Diabetes Metab Rev 14 129 151 9679667 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V 1:CAS:528:DyaK1cXltFGgsLw%3D (Pubitemid 28346261)
51. ILSI Health and Enviromental Sciences Institute (2009) 2009 Annual Report. http://www.hesiglobal.org/files/public/Annual%20Reports/ 2009AnnualReport.pdf. Accessed 28 July 2010
52. Apple FS, Murakami MM, Ler R et al. for the HESI Technical Committee of Biomarkers Working Group on Cardiac Troponins (2008) Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury. Clin Chem 54:1982-1998
53. S Amur F Frueh L Lesko, et al. 2008 Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective Biomark Med 2 305 311 20477416 10.2217/17520363.2.3.305 1:CAS:528: DC%2BD1cXnvFSgt7s%3D
54. U Welge-Lussen CA May AS Neubauer, et al. 2001 Role of tissue growth factors in aqueous humor homeostasis Curr Opin Ophthalmol 12 94 99 11224714 10.1097/00055735-200104000-00003 1:STN:280:DC%2BD3MzgtFylug%3D%3D (Pubitemid 32232079)
55. RC Tripathi J Li WF Chan, et al. 1994 Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2 Exp Eye Res 59 723 727 7698265 10.1006/exer.1994.1158 1:CAS:528:DyaK2MXjtFWntrk%3D